insights_auto
Why is GTBP down 4,17%?
Dive Deeperchevron_right
GTBP:NASDAQ
GT Biopharma Inc
US$6,20
arrow_downward
-4,17%(-0,27) 1D
US$6,45
arrow_upward
+4,03% (+0,25)bedtimeAfter hours
Closed: 1 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GTBP...
Open
US$6,34
High
US$6,46
Low
US$6,00
Mkt. cap
11,19 ລ້ານ
Avg. vol.
280,17 ພັນ
Volume
39,00 ພັນ
52-wk high
US$34,25
52-wk low
US$4,91
EPS
US$-35,41
Beta
0,91
Shares outstanding
1,80 ລ້ານ
No. of employees
1
Open
US$6,34
High
US$6,46
Low
US$6,00
Mkt. cap
11,19 ລ້ານ
Avg. vol.
280,17 ພັນ
Volume
39,00 ພັນ
52-wk high
US$34,25
52-wk low
US$4,91
EPS
US$-35,41
Beta
0,91
Shares outstanding
1,80 ລ້ານ
No. of employees
1
News stories
From web sources and news partners
AD HOC NEWS
·
26 ນາທີກ່ອນ
GT Biopharma sells USD 7.75 million: what it means for GT Biopharma stock
Stock Titan
·
2 ມື້ກ່ອນ
With $31.2M left to sell, GT Biopharma (GTBP) has made its first equity sale.
About GT Biopharma Inc
CEO-
Employees1
Founded1965
Headquartersແຊນ ຟຣານຊິສໂກ, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websitegtbiopharma.com